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Abstract 1 
Purpose: This study investigated the effect of induced alkalosis on the curvature constant (W’) of the power-2 
duration relationship under normoxic and hypoxic conditions. Methods: Eleven trained cyclists (mean ± SD) 3 
Age: 32 ± 7.2 yrs; body mass (bm): 77.0 ± 9.2 kg; VO2peak: 59.2 ± 6.8 ml·kg-1·min-1) completed seven laboratory 4 
visits which involved the determination of individual time to peak alkalosis following sodium bicarbonate 5 
(NaHCO3) ingestion, an environment specific ramp test (e.g. normoxia and hypoxia) and four x 3 min critical 6 
power (CP) tests under different experimental conditions. Participants completed four trials: alkalosis normoxia 7 
(ALN); placebo normoxia (PLN); alkalosis hypoxia (ALH); and placebo hypoxia (PLH). Pre-exercise 8 
administration of 0.3 g.kg-1 BM of NaHCO3 was used to induce alkalosis. Environmental conditions were set at 9 
either normobaric hypoxia (FiO2: 14.5%) or normoxia (FiO2: 20.93%). Results: An increase in W’ was observed 10 
with pre-exercise alkalosis under both normoxic (PLN: 15.1 ± 6.2 kJ vs. ALN: 17.4 ± 5.1 kJ; P = 0.006) and 11 
hypoxic conditions (ALN: 15.2 ± 4.9 kJ vs. ALN: 17.9 ± 5.2 kJ; P < 0.001). Pre-exercise alkalosis resulted in a 12 
larger reduction in bicarbonate ion (HCO3-) concentrations during exercise in both environmental conditions (p < 13 
0.001) and a greater blood lactate accumulation under hypoxia (P = 0.012). Conclusion: Pre-exercise alkalosis 14 
substantially increased W’, and therefore may determine tolerance to exercise above CP under normoxic and 15 
hypoxic conditions. This may be due to NaHCO3 increasing HCO3- buffering capacity to delay exercise-induced 16 
acidosis, which may therefore enhance anaerobic energy contribution.  17 
Key words: critical power, sodium bicarbonate, altitude, severe intensity domain  18 
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INTRODUCTION 1 
Fatigue is determined by an array of factors that are suggested to originate from afferent/efferent feedback from 2 
the central nervous system (i.e. central fatigue), and/or metabolic and biochemical alterations in the intramuscular 3 
regions (Ament and Verkerke, 2009). The mediators of fatigue are, however, predominantly dependant on exercise 4 
intensity and as such, the physiological response and tolerance to exercise can be clustered into distinct domains 5 
(Burnley and Jones, 2007). Tolerance within the severe intensity domain can be described by a mathematical 6 
hyperbolic curve known as the power-duration relationship (Jones et al. 2010; Poole et al. 2016). This hyperbolic 7 
curve can be categorised into the asymptote and the curvature constant, which in the power-duration relationship 8 
are known as critical power (CP) and W’, respectively. The CP signifies the greatest intensity where a 9 
physiological steady state can be maintained (Poole et al. 1988); whilst also defining the boundary between heavy 10 
and severe exercise intensity domains (Burnley and Jones 2007). The range of exercise intensities between CP 11 
and the power output at peak oxygen uptake (VO2peak) represent the W’. This quantifies a fixed work constant 12 
(measured in kilojoules (kJ)) available for exercise within the severe exercise intensity domain (Jones et al. 2010; 13 
Poole et al. 2016); and therefore, enables the prediction of time to exercise exhaustion at any given power output 14 
above CP. Exercise within the W’ range is associated with a distinct physiological response that are associated 15 
with fatigue (Poole et al. 1988; Burnley and Jones 2007; Jones et al. 2008). This includes, muscle metabolite 16 
perturbations, such as an exponential rise in muscle hydrogen cations (H+) and phosphocreatine (Pcr) breakdown 17 
(Jones et al. 2008); as wel as the development of a substantial VO2 slow component (Murgatroyd et al. 2011). 18 
The power-duration relationship has varying applications to healthy, patient and athletic populations. More 19 
specifically this includes; the normalisation and prescription of exercise intensities (Ferguson et al. 2013), a 20 
method to predict exercise performance capabilities (Black et al. 2014) and inform athletic pacing strategies 21 
(Vanhatalo, Jones and Burnley 2011). Furthermore, the critical power concept has been cited as a method that can 22 
assess the effect of interventions by providing both functional exercise capacity data and associated physiological 23 
benefits (Whipp and Ward, 2009; Jones et al. 2010). Therefore, greater mechanistic appreciation of the 24 
physiological components that determine CP and W’ may improve the practical application of this power-duration 25 
model. Critical power is sensitive to manipulation in O2 availability with hypoxic exposure diminishing CP 26 
(Derkerle, Mucci and Carter 2012; Simpson et al. 2015) and hyperoxic exposure increasing CP (Vanhatalo et al. 27 
2010). As such CP is suggested to be predominantly comprised of oxygen dependant, aerobic energy sources 28 
(Poole et al. 2016). In comparison, the determinants of W’ are less clear (Jones et al. 2010; Poole et al. 2016) as 29 
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interventions that increase CP can concurrently reduce W’ (Vanhatalo et al. 2010). This may indicate that W’ may 1 
not only represent the finite anaerobic energy contribution, as originally proposed, but rather an interplay of 2 
aerobic and anaerobic energetic factors.  3 
Muscle metabolite disturbances are closely linked with W’ (Jones et al. 2008) and the exogenous manipulation of 4 
metabolite disturbances can enhance W’; such as creatine ingestion to increase PCr resynthesise and thus W’ 5 
(Miura et al. 1999). This, however, has not been consistently demonstrated, as pre-exercise alkalosis (through 6 
NaHCO3 supplementation) was shown not to alter W’, despite the alleviation of H+ accumulation during all-out 7 
exercise (Vanhatalo et al. 2010). Indeed, there is considerable debate regarding the involvement of acidosis in 8 
fatigue and exercise performance (Westerblad 2016; Fitts 2016), which may explain the lack of improvement 9 
reported in W’. Morales-Alamo et al. (2015) observed that sprint performance following exhaustive exercise 10 
recovered at a faster rate than muscular acidosis (i.e. removal of H+). This suggests a close temporal relationship 11 
between acidosis and whole body exercise performance may not coexist. Furthermore, performance recovery was 12 
faster with hypoxic exposure, with the authors suggesting central fatigue mechanisms may have a more prominent 13 
role in fatigue in comparison to normoxia. This is despite acute hypoxia eliciting an additive acidic stress during 14 
exercise (Hogan, Cox and Welch 1983), which is identified as a factor contributing to the diminished exercise 15 
performance under this environmental stressor (Clarke et al. 2007). While, NaHCO3 supplementation is shown to 16 
be an effective ergogenic aid by acting to delay the onset of acidosis during exercise (McNaughton et al. 2008; 17 
2016), suggesting acid-base balance is implicated with exercise performance and fatigue. Furthermore, exercise 18 
above CP is associated with an increase in H+ and therefore, the hypothesis identifying acidosis as a physiological 19 
determinant of W’ utilisation cannot be dismissed. 20 
Theoretically, NaHCO3 may enhance W’ by increasing the availability of blood HCO3- and strengthen the 21 
physiochemical buffering capacity, which acts to dampen the rate of H+ accumulation during exercise (Carr et al. 22 
2011). More recent methodological developments in NaHCO3 administration suggest an inter-individual 23 
variability in extracellular peak blood alkalosis, which ranges from 10-140 min (Stannard et al. 2016; Miller et al. 24 
2016). Consequently, previous research utilising standard ingestion times across all participants may not have 25 
induced individual peak alkalosis, such as that used by Vanhatalo et al. (2010). Thereby limiting the potential to 26 
attain an accurate representation of the effect of alkalosis. The purpose of this study was therefore, to investigate 27 
the effect of individualised pre-exercise NaHCO3 supplementation on CP and W’ during the 3 min critical power 28 
test under normoxic and hypoxic conditions. 29 
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METHODS 
Participants 
Eleven male trained cyclists volunteered to participate in this study with the following mean ± SD physical 
characteristics, age 32 ± 7.2 yrs; body mass 77.0 ± 9.2 kg; VO2peak 59.2 ± 7.4 ml·kg-1·min-1; peak power output 
391.3 ± 43.7 W. Participant inclusion was determined by age (18-40 years), training history (minimum of two 
years cycling and a seven hrs·week-1 minimum training volume) and previous altitude exposure (not resided at 
altitude for the previous six months). Written informed consent was obtained from all participants after 
explanation of test procedures and associated risks. Ethical approval was obtained for the study from the 
Departmental Research Ethics Committee and the study was conducted in accordance with the Declaration of 
Helsinki.   
Experimental overview 
Participants visited the laboratory on seven separate days at the same time of day (± 1 hr), with visits separated 
by at least two, but no more than seven days. Participants were instructed to refrain from strenuous exercise and 
alcohol 24 hrs prior to each trial; while participants abstained from caffeine on the day of testing. Dietary intake 
was recorded 24 hrs preceding the initial trial, which was replicated for subsequent visits and confirmed verbally 
on the commencement of each trial. Participants were instructed to arrive in a 3 hrs postprandial state and a 
euhydrated state by maintaining fluid intake prior to arrival to limit confounding nutritional effects on exercise 
performance.   
During the first visit, individual time to peak blood alkalosis was established from the ingestion of 0.3 g·kg-1 body 
mass of NaHCO3 through mapping time course of blood response over 90 min (Miller et al. 2015). Capillary blood 
samples (70 µl) were taken prior to NaHCO3 ingestion followed by samples every 10 mins for 60 min post 
ingestion and then every 5 min from 60-90 mins. Samples were collected in a seated position from a sterilised 
finger into a capillary tube (Electrolyte balanced heparin clinitube, Radiometer, Denmark). Arterialisation was 
attained using an electric heated blanket (45 oC) for 5 min prior to sample collection (Yang et al. 2012). Samples 
were analysed for blood pH (Radiometer ABL90 Flex, Denmark) to determine the time taken for peak pH to 
transpire. This formed the timescale for individualised NaHCO3 ingestion during subsequent experimental trials. 
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Exercise trials were all conducted within a normobaric environmental chamber (Model S016r-7-sp TISS, UK), 
with ambient temperature (21 °C) and humidity (40%) regulated throughout. Fractional inspired oxygen (FiO2%) 
was adjusted for normoxic (FiO2 = 20.93%) and hypoxic (FiO2 = 14.5%) environmental conditions, which are 
equivalent to sea level and 3000 m, respectively. Environmental conditions were single blind and randomised 
during experimentation. A ‘sham hypoxic’ condition was created during the normoxic trials to mask the 
environmental conditions. This involved maintaining the oxygen (O2) controls to replicate auditory cues between 
conditions, a procedure previously used by Gallagher et al. (2014). Participants entered the chamber 10 min prior 
to exercise to allow equilibrium between atmospheric and body O2 stores (Andreassen and Rees 2005). 
The first two exercise trials consisted of an incremental ramp test assigned in a single-blinded, random order to 
either the normoxic or hypoxic environmental condition. A randomised, cross-over design was employed for the 
following four experimental trials under different environmental conditions. All exercise tests were performed to 
replicate the original ramp and 3 min all-out critical power test performed by Vanhatalo et al. (2007) to maintain 
the validity of the CP and W’ measured. The four experimental conditions were: alkalosis normoxia (ALN), 
placebo normoxia (PLN), alkalosis hypoxia (ALH), and placebo hypoxia (PLH). Supplements were administered 
in a double-blinded manner prior to exercise at the time to peak alkalosis identified in the initial trial. Participants 
ingested 0.3 g·kg-1 body mass of NaHCO3 or a placebo of sodium chloride (NaCl) at 0.21 g·kg-1 body mass, which 
was calculated as an equimolar sodium concentration to the NaHCO3 dose. Supplements were mixed with 400 ml 
of water and 50 ml of sugar free orange flavoured cordial, which were ingested within a five min period. Capillary 
blood samples were taken during experimental trials on three occasions (Pre-supplement, Pre-exercise and within 
1 min Post exercise) using the method described earlier. Samples were analysed for blood H+ concentrations ([H+]), 
bicarbonate ions concentration ([HCO3-]), blood lactate concentration ([bla]) and O2 saturation percentage (SpO2), 
blood oxygen (PO2) and carbon dioxide (PCO2) partial pressure (Radiometer ABL90 Flex, Denmark). 
Determination of VO2peak and Ventilatory Threshold 1 
All exercise trials were conducted using an electromagnetically braked cycle ergometer (Lode Excalibur Sport, 
Groningen, The Netherlands). Participants adjusted the ergometer seat and handle bars to maximise comfort, this 
was recorded in the first trial and replicated for all subsequent trials. The incremental ramp test was performed 
with the ergometer in isokinetic mode and was proceeded by a 5 min unloaded warm up. The test commenced at 
75 W for 1 min and followed by continuous increase of 1 W every 2 s (30 W·min-1). Participants selected a 
preferred cadence (80 rpm, n = 5; 90 rpm, n = 6) to maintain throughout the test until volitional exhaustion. This 
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test was terminated when cadence fell by more than 10 rpm from the preferred cadence for more than 5 s, despite 
strong verbal encouragement.  
Breath-by-breath pulmonary gas exchange and heart rate was measured throughout the incremental ramp test, and 
all subsequent trials, using a free standing metabolic gas analyser (K5, Cosmed, Italy). Calibration was performed 
prior to every test in accordance with manufacturer’s instructions. Pulmonary gas exchange data was initially 
smoothed, by 4 standard deviations from the mean, to remove errant data points caused by coughing or 
swallowing. Data was then averaged to 10 s bins for the identification of the first ventilatory threshold (VT1). The 
VT1 was detected through inflection points on gas exchange graphs using the following criteria: 1) the v-slope 
method through the breakpoint in VCO2/VO2 against time; 2) an increase in VE/VO2 but no increase in VE/VCO2; 
and 3) an increase in PETO2 without a decline in PETCO2 (Beaver, Wasserman and Whipp 1986). The subsequent 
power output associated with the VT1 was then used to determine the linear factor for the 3 min critical power 
test (as described below).  Peak power output (PPO) was defined as the greatest power output attained at the 
termination of the test. Peak oxygen uptake was defined as the highest 5 s rolling average of VO2. Furthermore, 
cardiopulmonary data including peak VE and RER; and average VE/VCO2, VE/VO2, PETCO2 and PETO2 were 
documented.  
Critical power test 
The CP test consisted of an initial 3 min unloaded baseline pedalling at a preferred cadence followed by the 
commencement of the 3 min maximal sprint phase. On the sprint phase the ergometer was set on the linear mode 
which provides a fixed resistance. This linear factor (linear factor = power/cadence2) was calculated to determine 
a fixed resistance that results in the participants preferred cadence (used during the incremental ramp protocol) to 
be attained at a power output that corresponds to the mid-point of peak power output and the VT1 intensity. This 
linear factor was determined for the respective environmental condition to avoid substantially larger 
determinations of W’ under hypoxia (Simpson et al. 2015). During the last 10 s of unloaded pedalling, participants 
were asked to increase cadence to 120 rpm, and given a countdown into the commencement of the sprint phase. 
Participants were instructed to attain a peak power on sprint phase initiation and hold the cadence as high as 
possible throughout test duration. Strong verbal encouragement was provided by the same researcher throughout 
the study and information of cycling cadence was given during the test, whilst information related to performance 
and time elapsed was withheld, to avoid pacing. Familiarisation to the critical power test was conducted following 
a 30 min recovery after the second incremental ramp test, a design that has previously been shown to retain the 
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validity of the 3 min CP test (Constantini et al. 2014). The determination of CP and W’ using the 3 min test has 
been subject to criticism due to the suggested overestimation of the CP parameter (Bergstrom et al. 2013), 
therefore, a minimal 30 s rolling average was taken as CP and the total work performed above CP as W’. This 
replicates the analysis previously used by Shearman et al. (2015) who found a lower intensity than the original 
CP determination method, thus limiting the risk of overestimation. In addition, the original identification of CP 
through last 30 s end power output, and the total work performed above this power output, was calculated for 
comparative purposes and defined as EP and W’EP. The PPO was determined as the greatest 5 s average power 
output recorded during the CP test. While, heart rate was recorded throughout the exercise test (T31, Polar, 
Finland) and participant were asked to rate perceived exercise (RPE) using the 6-20 point Borg scale at the end 
of exercise.   
Statistical Analysis 
The Shapiro-Wilk test provided no evidence to reject the hypothesis that all data was normally distributed. A two-
way ANOVA (condition [normoxia vs. hypoxia] x time] was used to compare power outputs of VT1 and PPO 
during the incremental ramp test, whilst cardiopulmonary variables between environmental conditions were 
compared using a paired t-test. A two-way (treatment [alkalosis vs. placebo] x condition [normoxia vs. hypoxia]) 
repeated measures ANOVA was used to compare means for dependant variables within the 3 min CP test (CP, 
W’, total work done (TWD), PPO, and HR) and RPE. A three way (treatment [alkalosis vs. placebo] x condition 
[normoxia vs. hypoxia] x time [pre-supplementation vs. pre-exercise vs. post exercise]) repeated measures 
ANOVA was conducted to compare blood [HCO3-] and [H+], PO2 and PCO2, whilst further comparison of change 
in blood [HCO3-], [H+] and lactate during exercise were conducted through a two-way ANOVA. Furthermore, a 
comparison of CP to EP and W’ to W’EP was performed using a two-way ANOVA. Where significant main effects 
were found, a Bonferroni correction was used for post-hoc pair-wise analyses. Effect size were calculated using 
partial eta squared (ηp2) and interpreted as small (< 0.01), medium (0.01 - 0.06) and large effect (≥ 0.14) (Cohen 
1988). Pearson correlations were performed to examine the relationship between the effect of NaHCO3 on TWD 
and the effect on W’ and CP, under both environmental conditions. A magnitude based inferences approach was 
used to detect the likely practical outcome of the intervention (Batterham and Hopkins 2006). The smallest 
meaningful change was assessed against a Cohen unit of 0.2. This contemporary statistical inference method 
provides an interpretation on the magnitude of an effect against a pre-determined smallest meaningful effect from 
the treatment. This, therefore, substantiates inferences from null hypothesise significance testing and effect sizes, 
8 
 
whilst also reducing inferential error rates (Hopkins and Batterham, 2016). The following qualitative descriptors 
were applied to quantitative percentile scores: (1) 25-75% possible; (2) 75-95% likely; (3) 95-99% very likely and 
(3) >99% most likely. Instances where the likelihood of a beneficial or negative effect were >5%, the qualitative 
interpretation was deemed to be unclear.  Descriptive data is presented as mean ± SD and statistical significance 
accepted at p < 0.05. Data were analysed using SPSS v22 for Windows (SPSS Inc., Chicago, IL, USA), except 
for magnitude based inferences which were calculated through an online spreadsheet (Batterham and Hopkins 
2006). 
Results 
During the preliminary trial, time to peak pH following 0.3 g·kg-1 bm of NaHCO3 ingestion ranged between 40-
70 min (mean: 50 ± 9.6 min). Ingestion of NaHCO3 during subsequent trials demonstrated a good correlation with 
the individualised dose response trial with an ICC of 0.6; and a standard error of measurement as 0.007 and 0.006 
for trials ALN and ALH, respectively. A significant interaction between environment was found (p = 0.005; ηp2 
= 0.57) on peak power during the ramp test (Table 1). This was represented in peak power output reducing by 
10% (p < 0.001) between normoxia to hypoxia; although power output at VT1 was similar between environmental 
conditions (p = 0.38). There was also a significant 18% reduction in VO2peak between normoxic to hypoxic 
environment (p = 0.001).  
Pre-exercise alkalosis had a significant main effect on W’ (p < 0.001; ηp2 = 0.7) (Figure 1) and TWD (p = 0.015; 
ηp2 = 0.46) (Figure 2). This represents a 14% increase in W’ under normoxic (p = 0.006) and an 18% increase 
under hypoxic (p = 0.001) conditions with NaHCO3 compared to placebo. Accordingly, magnitude based 
inferences determined a very likely effect under normoxia and most likely effected under hypoxia (Table 3). Pre-
exercise alkalosis also elicited a positive effect on TWD, with post hoc comparisons showing a 5.5% (p = 0.048) 
and 4.8% (p = 0.01) increase under normoxic and hypoxic environments, respectively. In contrast, there was no 
supplement effect on CP (p = 0.41; ηp2 = 0.06). Critical power was, however, effected by the environmental 
conditions (p < 0.001; ηp2 = 0.8), with an overall mean reduction of 44.5 ± 23.2 W (Table 2). Similarly, an overall 
significant environmental effect on TWD was found (p < 0.001; ηp2 = 0.8) with hypoxia eliciting a mean 10.7% 
reduction. Conversely, W’ was not influenced by the environmental conditions (p = 0.59; ηp2 = 0.02). Comparison 
of CP to EP demonstrated an overall significant main effect across conditions (p = 0.004; ηp2 = 0.73), although 
pairwise comparisons were non-significant; while W and W’EP did not differ (p = 0.210; ηp2 = 0.15). Pearson’s 
correlation between the effect of alkalosis reported a significant relationship between the effect on TWD and the 
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effect on CP under normoxic (r = 0.92; p < 0.001) and hypoxic environments (r = 0.83; p = 0.001). Whereas, the 
relationship between the effect on TWD and W’ was not significantly different under normoxia (r = 0.52; p = 
0.09) and hypoxia (r = 0.2; p = 0.54). 
A significant two-way [supplement x time] interaction was detected on [HCO3-] (p < 0.001; ηp2 = 0.19) and [H+] 
(p < 0.001; ηp2 = 0.78), indicating NaHCO3 supplementation had a significant effect on blood [HCO3-] and [H+] 
(p < 0.001) as displayed in figure 2. A significant main effect with alkalosis was evident on change in [HCO-] 
during exercise (p < 0.001; ηp2 = 0.68), although the environmental effect was not significant (p = 0.615; ηp2 = 
0.02). Further, pairwise comparisons revealed a 28% (p < 0.001) and 27% (p < 0.001) greater increase in [HCO-] 
reduction with pre-exercise alkalosis in the respective normoxic and hypoxic trials, compared to placebo (Figure 
2). Equivalently, blood [lactate] change during exercise was significantly increased with alkalosis by 10% under 
normoxia and 15% under hypoxia (Table 2) (p = 0.005; ηp2 = 0.54) but environmental conditions had no influence 
(p = 0.41; ηp2 = 0.06). Despite this, the significant supplement effect on change in [bla] only manifested during 
hypoxic conditions (mean difference = - 2.22 nM; p = 0.012) but not during normoxic conditions (mean difference 
= - 1.58 nM; p = 0.08). In contrast, change in [H+] from pre to post exercise did not change with neither a 
supplement (p = 0.82; ηp2 = 0.01) nor environment (p = 0.38; ηp2 = 0.07) effect (Figure 2). Furthermore, mean 
values of PO2 and PCO2 across conditions are reported in table 4.  
Discussion 
This study was designed to determine the effect of NaHCO3 on the W’ parameter of power-duration relationship. 
The principle and novel finding was that attaining individualised peak blood alkalosis, appears to enhance the 
magnitude of W’ under both normoxic and hypoxic conditions. Furthermore, an increase in total work done across 
the 3 min exercise period was evident; along with greater reduction in blood [HCO-] and increased [bla] during 
exercise with pre-exercise NaHCO3 treatment. This investigation also revealed the magnitude of CP declines under 
moderate hypoxic exposure, supporting previous research (Dekerle et al. 2012; Simpson et al. 2015; Shearman et 
al. 2016). However, manipulation of acid-base status was deemed to have no effect on CP determination. 
Therefore, NaHCO3 may be an effective ergogenic aid by increasing work performed above CP and, also, the total 
work performed in the severe intensity domain.  
The primary finding of the study is in contrast with previous research by Vanhatalo et al. (2010), who, in a 
normoxic environment, reported no effect with NaHCO3 ingestion on the W’ parameter. The exercise protocols 
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in both studies were matched, although the calculation of W’ did however differ, with W’ determined from the 
final 30 sec power output by Vanhatalo et al. (2010) whereas the present study used the lowest 30 s average power 
output. There were no significant differences in the current study, however, in W’ between the methods of 
calculation and therefore this is not likely to explain the differences. There are, however, two main methodological 
differences that may explain the opposing finding. Recent research has identified exogenous NaHCO3 ingestion 
is subject to inter-individual variance in blood pH and HCO3- (Miller et al. 2016, Stannard et al. 2016). The current 
investigation accounted for this varied blood analyte response through individualised NaHCO3 administration 
prior to exercise, which ranged from 40 to 70 min and represented a significant increase in blood alkalinity and 
[HCO3-] prior to exercise (figure 2). The only previous investigation to employ this NaHCO3 administration 
protocol reported a larger variance between 10 to 90 min to peak alkalinity within in a recreationally active cohort 
(Miller et al. 2016). On this premise, it is reasonable to suggest that the standardised 60 min pre-exercise ingestion 
used by Vanhatalo et al. (2010) may not have induced maximal peak alkalosis within all participants; thereby 
masking the influence of alkalosis on W’. The differing results with the current study could also be attributed to 
the training status of participants used, as the ergogenicity of NaHCO3 has been suggested to be greater in trained 
individuals (Carr, Hopkins and Gore, 2011; McNaughton et al. 2016). Alternatively, the differing results could be 
attributed to the recently identified inter-individual variability in performance response to NaHCO3 
supplementation (Saunders et al. 2014a; Dias et al. 2016) 
The magnitude based inference analysis determined the ergogenic effect of sodium bicarbonate on W’ to be ‘very 
likely’ and ‘most likely’ under normoxic and hypoxic conditions, respectively. The current investigation is the 
first to demonstrate a significant and meaningful improvement in performance from NaHCO3 under acute hypoxic 
conditions, in contrast with as previous investigations reporting no effect (Saunders et al. 2014b; Flinn et al. 2014). 
The conflicting results to previous investigations may be attributed to the intensity and type of exercise, which 
were supra-maximal and intermittent in both previous studies, or the training status of participants, who were 
recreationally trained. Furthermore, it should be acknowledged that acidosis is suggested not to be an important 
contributor to fatigue at hypoxia; indeed, maximal repeated sprint performance is shown to be independent of the 
presence of muscular acidosis following exhaustive exercise (Morales-Alamo et al. 2015). While other 
investigations have reported findings in direct contract by suggesting acidosis can better maintain performance at 
hypoxia (Schone et al. 1983; Fulco et al. 2006). Therefore, importance of alkalosis on exercise performance cannot 
be concluded from the observations of the current study and both acidosis and alkalosis may be beneficial to 
performance though differing mechanism of action. Interestingly, the magnitude based inferences revealed a 
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larger effect of NaHCO3 under hypoxia compared to normoxia, which may be due to the greater acidic stress and 
the subsequent increased reliance on the HCO3- buffering system during exercise. However, 3 min CP protocol 
was not primarily designed as a sensitive measure to detect changes in overall performance but rather establish 
CP and W’. Therefore, the use of fixed intensity exercise tolerance protocol, such as the Cycling Capacity Test 
110% (Saunders et al. 2014a), may provide a more appropriate high-intensity protocol to test the difference in 
efficacy of NaHCO3 between hypoxic and normoxic environments.  
This study provides a unique mechanistic insight into the determinants of W’, which is subject to uncertainty 
within scientific literature (Poole et al. 2016), given the multi-faceted central and peripheral mechanisms of 
exercise tolerance and fatigue (Amet and Verkerke, 2009). Using 31P magnetic resonance spectroscopy (MRS) 
muscle metabolite responses to exercise above CP have been characterised, with a rapid accumulation of H+ and 
Pi observed (Jones et al. 2008). Acidosis is associated with exercise above CP and is likely to, at least in part, 
contribute to exercise intolerance at intensities within the severe intensity domain. Moreover, alleviating acidosis 
is shown to result in increased muscle glycogen utilisation (Hollidge-Horvat et al. 1999; Percival et al. 2015), and 
given the association between glycolytic flux and W’ (Miura et al. 2000), it is conceivable that increased glycolysis 
with alkalosis may contribute to an increased W’. Pre-exercise NaHCO3 supplementation enables an increased H+ 
efflux from the intramuscular regions to the extracellular blood compartments (Roth and Brooks 1990), which 
corresponds to a reduction in the rate of intramuscular H+ accumulation during exercise (Stephens et al. 2002) and 
a concomitant increase in intramuscular glycogen utilisation (Percival et al. 2015). Therefore, the overall 
improvement in W’ and total work done in this study could be attributed to the blood acid-base biochemical 
changes during exercise. Indeed, a significantly greater reduction in blood [HCO-] during exercise with alkalosis 
is indicative of a superior HCO3- buffering activity during exercise. Thereby, attenuating the rate of H+ 
accumulation and thus, actively delaying acidosis development. Furthermore, a significant increase in [bla] was 
evident following NaHCO3 treatment in comparison to placebo by 15% under hypoxic conditions and non-
significant difference of 10% under normoxia. This enhanced lactate accumulation presents an indirect biomarker 
of upregulated glycolytic flux during exercise, which has been cited as the mechanism by which NaHCO3 is 
ergogenic (Hollidge-Hovart et al. 1999). This significant [bla] increase under hypoxia may also explain the greater 
magnitude of effect in hypoxia. Accordingly, it is proposed that a combination of enhanced intramuscular H+ 
efflux and increased glycolytic flux offers mechanistic explanations to the enhanced W’ and improved TWD with 
NaHCO3. 
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Nevertheless, this study did not directly quantify anaerobic energy contribution and therefore, the improved W’ 
and TWD cannot be directly attributed to an increased glycolytic flux. Despite lactate cited as an indirect marker 
of glycolysis, the increase observed could also be explained by a reduction in lactate uptake by inactive tissue 
(Grainier et al. 1996) or an increased lactate efflux working intramuscular regions to extracellular space (Bishop 
et al. 2006) from the supplementation of NaHCO3. Furthermore, a recent investigation has suggested anaerobic 
exercise is not hindered with acidosis (Morales-Alamo et al. 2015) and therefore without assessment of 
appropriate glycolytic enzyme activity and muscle glycogen utilisation in this study, the increased anaerobic 
energy contribution can only be hypothesised. While it may be intuitive to identify W’ as an indicator of anaerobic 
energy supply, more recent definitions have suggested a relationship with VO2 kinetics (Poole et al. 2016). As 
such, alterations in O2 delivery and utilisation may also effect W’. Indeed, Nielson et al. (2002) found an improved 
maintenance in SPO2 during a maximal 2000 m rowing with constant infusion of HCO3- to maintain homeostatic 
pH during exercise; which the authors cited as a reason for the improved exercise performance. In the current 
study, end exercise SPO2 did not differ between conditions, however, this may be due to constant infusion of 
HCO3- in the previous study compared to a single pre-exercise bolus in the current investigation. It is conceivable 
that differences in SPO2 response during exercise may have occurred in the current study. However, continuous 
measurement of SPO2 were not taken and therefore increased O2 delivery during exercise cannot be ruled out as 
a potential mechanism for the improved W’ and TWD. 
An interesting observation in this study was the strong correlation between the effect of alkalosis on TWD and on 
CP under normoxia and hypoxia. Therefore, highlighting the substantial effect changes in CP can have on TWD, 
which may be explained as CP represented a larger proportion of intensities up to VO2peak, in comparison to the 
severe intensity domain alone (Burnley and Jones, 2016). However, no significant main effect of induced alkalosis 
on CP was noted, suggesting pre-exercise alkalotic inducement has no clear benefit on exercise performance at 
intensities at or below CP. This is expected, given a steady state of [H+] is maintained within 3 min of exercise at 
the CP intensity (Jones et al. 2008). Nonetheless, pre-exercise NaHCO3 supplementation has been demonstrated 
to improve exercise tolerance at CP by 23.5% (Mueller et al. 2013). Supporting research addressing the ergogenic 
effect of induced alkalosis on lower intensity exercise performance is scant; however, research does suggest 
alkalosis can improve performance up to 60 min (McNaughton, Dalton and Palmer 1999). Despite the results of 
the current investigation, the ergogenic effect of longer duration activities at or below CP intensity cannot be 
dismissed; although potential ergogenic benefits are likely to more efficacious within W’ exercise intensity ranges. 
Equally, the likelihood of alkalosis to exhibit a negative impact on CP should not be dismissed. Alkalosis increases 
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muscle glycogen utilisation (Percival et al 2015), and due to the association between low muscle glycogen and a 
lower CP (Muira et al. 2000), it is appropriate to hypothesise NaHCO3 may diminish CP further during prolonged 
exercise. 
The current study was designed to determine the effect of NaHCO3 on the W’ parameter of the power-duration 
relationship under normoxia and acute hypoxia. However, the use of a single acute hypoxic magnitude may limit 
the generisability of the results to alternative hypoxic doses. Indeed, medium term (3 days) severe altitude 
exposure (5050 m) is suggested to negatively impair both CP and W’ (Valli et al. 2011). Therefore, the response 
to NaHCO3 may be different under more severe hypoxic exposures and with a prolonged exposure. Nevertheless, 
the current study provides an insight into the NaHCO3 under an acute moderate hypoxic dose, common to 
environments athletes may train. A further limitation is that respiratory data was not collected during the 3 min 
CP test and therefore, the cardiopulmonary response to the environmental and supplemental interventions cannot 
be distinguished. Nevertheless, HRpeak and RPE did not differ between conditions suggesting exercise intensity 
was equivalent between conditions. It should also be highlighted that the low PO2 values were not reflective of an 
arterialised blood sample, suggesting our arterialisation technique was not effective. Nevertheless, blood gas 
parameters (e.g. pH and HCO3-) are suggested to unaltered between arterialised and non-arterialised blood samples 
(Stannard et al. 2016) and therefore, the results remain valid; while also remaining consentient with previous 
scientific literature (Flinn et al. 2014; Saunders et al. 2014a; Sauders et al. 2014b; Dias et al. 2016; Miller et al. 
2016) Furthermore, it is suggested future investigations should consider obtaining muscle biopsy and 
arteriovenous balance analysis to understand the metabolic response to NaHCO3 ingestion on W’.  
Conclusion  
This study is the first to demonstrate that pre-exercise alkalosis has a beneficial effect on W’ under normoxic and 
hypoxic conditions. This was accompanied by a greater blood [HCO-] reduction and an increased [bla] during 
exercise with alkalosis, which present indirect markers of HCO3- buffering activity and glycolytic flux. Taken 
together, it suggests W’ may be enhanced through improved regulation of acid-base status during exercise, which 
may mediate an increase in anaerobic energy contribution. Furthermore, this study also demonstrated that 
individualised NaHCO3 ingestion improved TWD during the 3 min exercise test, whilst also being the first 
investigation to report the ergogenic effects of NaHCO3 under acute hypoxia.  
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Figure Legends 
Figure1. Graph (a) displays W’ and graph (b) displays TWD. These figures represent the mean values in each 
experimental condition, while the individual points and connecting lines represent the individual response to 
alkalosis under the receptive environmental conditions. * represents significantly different to placebo condition 
(p < 0.05). 
Figure 2. Graph (a) displays change in blood [H+] and graph (b) displays change in blood [HCO-] across three 
time points during the four different experimental trials. Error bars are displayed as SEM. * represents 
significantly different from pre-supplement and pre-exercise time points (p < 0.05); # represents significantly 
different from placebo conditions at the same time point. 
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Table 1. RAMP test result under normoxic and hypoxic conditions. 
 
 
 
 
 
 
 
 
 
 
 
*denotes significantly different to Hypoxia (p < 0.05). Values reported as a mean ± SD.  
 
Variables Normoxia Hypoxia 
VO2 max (ml.kg
-1.min-1) 59.3 ± 7.4* 48.5 ± 6.0 
PPO (W) 390.4 ± 45.0* 351.5 ± 40.1 
VT1power (W) 176.36 ± 18.17 166.8 ± 19.4 
VEpeak 151.2 ± 34.2 151.3 ± 35.3 
RER 1.2 ± 0.1 1.3 ± 0.2 
VE/VCO2 24.6 ± 5.5* 31.4 ± 6.8 
VE/VO2 24.5 ± 2.8* 28.6 ± 4.4 
PETO2 (mm Hg) 87.1 ± 25.7* 60.8 ± 14.0 
PETCO2 (mm Hg) 47.3 ± 3.9* 35.0 ± 6.7 
HRpeak (bpm) 181 ± 6.6 179 ± 7.1 
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Table 2. Overview of 3-min all-out critical power test data 
Variables PLN ALN PLH ALH 
CP (W) 304.2 ± 40.0* 313.2 ± 48.5* 263.3 ± 34.3 264.8 ±3 
W’ (kJ) 15.1 ±6.2# 17.4 ± 5.1 15.2 ± 4.9# 17.9 ± 5.2 
EP (W) 308.2 ± 43.3 314.2 ± 55.5 267.0 ± 31.7 267.1 ± 29.4 
W’EP (kJ) 14.1 ± 6.3 17.1 ± 5.0 14.5± 5.6 17.4 ± 5.2 
TWD (kJ) 69.9 ± 10.2*# 73.8 ± 10.5* 62.6 ± 7.2# 65.6 ± 6.0 
PPO (W) 697 ± 91 694 ± 87 694 ± 90 695 ± 86 
Blood Lactate (mmol·l-1) 13.9 ± 5.2 15.5 ± 7.0 14.7 ± 6.4
# 16.5 ± 5.4 
HRpeak (bpm) 175.1 ± 7.1 175.3 ± 6.8 175.8 ± 7.4 176.1 ± 6.9 
SpO2 (%) 94.0 ± 2.1* 93.7 ±2.3* 83.5 ± 7.1 84.4 ± 3.9 
RPE 18.8 ± 1.8 19.3 ± 1.6 19.0 ± 1.9 19.3 ± 1.6 
PLN represents the placebo normoxia condition. ALN represents the alkalosis normoxia condition. PLH represents the 
placebo hypoxia condition. ALH represents the alkalosis hypoxia condition. Blood lactate represents blood lactate 
accumulation during exercise 
*denotes significantly different to corresponding hypoxic trial (P < 0.001). 
 # denotes significance to corresponding alkalosis trial (p<0.001).  
Values reported as a mean ± SD. 
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Table 3. Magnitude based inference of performance effects from sodium bicarbonate supplementation compared 
to placebo at sea level and hypoxic environments 
 
 
Non-clinical magnitude based inferences are interpreted with the criteria outlined in the statistical analysis section.  
ENVIRONMENTAL 
CONDITION 
VARIABLE MEAN DIFFERENCE 
(90% CONFIDENCE 
INTERVAL 
NON-CLINICAL MBI 
SEA LEVEL 
TWD (kJ) 3.9 (± 3.1) Very likely  
W’ (kJ) 2.3 (± 1.7) Very likely 
CP (W) 9.0 (± 14.9) Unclear 
HYPOXIA 
TWD (kJ) 3.0 (± 1.2) Most likely 
W’ (kJ) 2.8 (± 1.1) Most likely 
CP (W) 1.4 (± 9.8) Unclear 
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Table 4. Blood PO2 and PCO2 during the CP experimental trials  
PLN represents the placebo normoxia condition. ALN represents the alkalosis normoxia condition. PLH represents the 
placebo hypoxia condition. ALH represents the alkalosis hypoxia condition. * denote significant difference from placebo 
condition in the same environmental condition  
Variables PLN ALN PLH ALH 
Pre-supplement PCO2 (kPa) 5.3 ± 0.5 5.5 ± 0.5 5.1 ± 0.6  5.4 ± 0.6* 
Pre-exercise PCO2 (kPa) 5.8 ± 0.3 5.7 ± 0.2 5.4 ± 0.4 5.7 ± 0.5 
Post-exercise PCO2 (kPa) 5.2 ± 0.4 5.4 ± 0.5 5.1 ± 0.5 5.4 ± 0.5* 
Pre-supplement PO2 (kPa) 9.0 ± 1.5 8.7 ± 1.3 8.3 ± 1.5 8.3 ± 2.0 
Pre-exercise PO2 (kPa) 8.2 ± 1.3 8.6 ± 0.9 8.3 ± 1.7 8.5 ± 2.1 
Post-exercise PO2 (kPa) 
9.0 ± 3.7 10.0 ± 2.1 9.0 ± 2.0 7.6 ± 1.4 
 
